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Abstract
Background: Physical inactivity increases the risk of many chronic diseases including coronary heart disease, type 2
diabetes and some cancers. It is recommended that adults should undertake at least 150 minutes of moderate
intensity physical activity throughout the week but many adults do not achieve this. An opportunity for working
adults to accumulate the recommended activity levels is through the daily commute.
Methods: Employees will be recruited from workplaces in south-west England and south Wales. In the intervention
arm, workplace Walk-to-Work promoters will be recruited and trained. Participating employees will receive Walk-to-
Work materials and support will be provided through four contacts from the promoters over 10 weeks. Workplaces in
the control arm will continue with their usual practice. The intervention will be evaluated by a cluster randomized
controlled trial including economic and process evaluations. The primary outcome is daily minutes of moderate to
vigorous physical activity (MVPA). Secondary outcomes are: overall physical activity; sedentary time; modal shift away
from private car use during the commute; and physical activity/MVPA during the commute. Accelerometers, GPS
receivers and travel diaries will be used at baseline and one year follow-up. Questionnaires will be used at baseline,
immediately post intervention, and one year follow-up. The process evaluation will examine the context, delivery and
response to the intervention from the perspectives of employers, Walk-to-Work promoters and employees using
questionnaires, descriptive statistics, fieldnotes and interviews. A cost-consequence study will include employer,
employee and health service costs and outcomes. Time and consumables used in implementing the intervention will
be measured. Journey time, household commuting costs and expenses will be recorded using travel diaries to estimate
costs to employees. Presenteeism, absenteeism, employee wellbeing and health service use will be recorded.
Discussion: Compared with other forms of physical activity, walking is a popular, familiar and convenient, and the
main option for increasing physical activity in sedentary populations. To our knowledge, this is the first full-scale
randomised controlled trial to objectively measure (using accelerometers and GPS receivers) the effectiveness of a
workplace intervention to promote walking during the commute to and from work.
Trial registration: ISRCTN15009100 (10 December 2014).
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Background
Physical inactivity increases the risk of many chronic
diseases including coronary heart disease, type 2 dia-
betes, obesity and some cancers [1]. It is currently rec-
ommended that adults should undertake at least
150 minutes of moderate intensity physical activity in
bouts of 10 minutes or more throughout the week [1-3].
There are concerns that many adults in the United
Kingdom and other high-income countries do not
achieve this [1,3-5].
Increasing physical activity levels, particularly among
the most inactive, is an important aim of current public
health policy in the UK [1,6]. There is also increasing
interest in the relationship between time spent sedentary
and poor health outcomes [7] and consequently UK
health guidelines recommend that adults should minim-
ise the amount of time spent sedentary (sitting) in
addition to increasing physical activity [1].
Adult obesity levels may be linked to travel behaviour,
one indicator of which is that countries with highest
levels of active travel tend to have the lowest obesity
rates [8]. Walking is a carbon neutral mode of transport
that has declined in recent decades in parallel with the
growth in car use [1]. Walking has been described as the
nearest activity to perfect exercise [9]. It is a popular, fa-
miliar, convenient and free form of exercise that can be
incorporated into everyday life and sustained into older
age. Even walking at a moderate pace of 5 km/h (3miles/h)
expends sufficient energy to meet the definition of
moderate intensity physical activity [10]. Hence there are
compelling reasons to encourage people to walk more, not
only to improve their health but to address the problems
of climate change [11-14].
In the UK, there are substantial opportunities to in-
crease walking by replacing short journeys undertaken
by car. For example, the 2011 National Travel Survey
showed 22% of all car trips were shorter than two miles
in length, while 18% of trips of less than one mile were
made by car [15]. An opportunity for working adults to
accumulate the recommended moderate activity levels is
through the daily commute and, in addition, replacing
the car for short journeys is likely to reduce sedentary
time. Experts in many World Health Organisation
(WHO) countries agree that significant public health
benefits can be realised through greater use of active
transport modes [16]. Furthermore, cost benefit analysis
for the UK Department for Transport suggests the ratio
of benefits to costs are high [17].
A systematic review comparing direct versus self-
report measures for assessing physical activity in adults
found self-report measures provided were higher esti-
mates of physical activity than objective measures in
some cases and lower values in others [18]. This calls
into question the reliability of self-report measures, and
indicates there is no approach to correcting for self-
report measures that will be valid in all cases. However,
very few studies have objectively measured the contribu-
tion of walking, particularly walking to work, to adult
physical activity levels and more evidence is needed [19].
Systematic reviews have examined the effectiveness of
interventions to promote physical activity in general
[20-23] but there is less evidence about how best to pro-
mote walking to work. Available systematic review evi-
dence has focused on: interventions that promote
walking; [24] interventions that promote walking and
cycling as an alternative to car use [23], and; the effect-
iveness of workplace physical activity interventions [25].
NICE public health guidance on workplace health pro-
motion concluded that although schemes exist to en-
courage employees to walk or cycle to work, little is
known about their impact [26]. Few studies used robust
data collection methods to measure the impact of work-
place interventions on employees’ physical activity levels,
with most using self-report. There was also a lack of in-
formation about how interventions are influenced by the
size and type of workplace and the characteristics of
employees.
In 2011 the National Institute for Health Research Pub-
lic Health Research (NIHR-PHR) programme funded the
Walk to Work feasibility study (Project 10/3001/04) which
incorporated Phase I development of a behavioural inter-
vention followed by a Phase II exploratory trial in 17
workplaces in Bristol [27,28]. The intervention was tested
in small, medium-sized and large workplaces, used object-
ive measures of physical activity, and included process
evaluation and an assessment of costs. Results from the
feasibility study demonstrated that the intervention and its
evaluation were feasible and funding was granted for a
full-scale cluster randomised controlled trial commencing
1 November 2014 for 33 months.
Methods/Design
Aim
The overall aim of the research is to examine the effect-
iveness and cost effectiveness of an employer-led scheme
to increase walking during the commute.
Study design and setting
The study is a multi-centre cluster randomised con-
trolled trial in 84 workplaces in south-west England and
south Wales, and incorporates process and economic
evaluations. The intervention will be implemented in 42
workplaces; 42 workplaces will comprise the control
arm.
The intervention
Workplace ‘Walk-to-Work promoters’ will be identified
(volunteers, or nominated by participating employers)
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and receive a half-day training package provided by
public health and transport specialists about the bene-
fits of walking during the commute and how to pro-
mote increased walking either by walking the entire
route or mixing walking with other transport modes.
The Walk-to-Work promoters will be given resource
packs and trained to access relevant websites and toolk-
its. They will also be trained in the use of specific be-
haviour change techniques that form the basis of the
intervention, including: providing information on the
link between walking and health; prompting intention
formation; identifying barriers to walking and ways to
overcome them; prompting goal setting; prompting self-
monitoring; identifying social support and encouragement;
reviewing goals, and; relapse prevention. There is evidence
that these techniques are effective in achieving behaviour
change [29,30] and can be effectively delivered by non-
specialists. Additional booklets will be provided for em-
ployers/managers with information and ideas of how
the workplace can support increased walking during the
daily commute.
Participating employees will be contacted by the
Walk-to-Work promoter and given a Walk-to-Work
pack including an information booklet, travel diary and
pedometer. Goals for incorporating walking into the
journey to and from work will be set. Further encourage-
ment will be provided through four contacts from the
Walk-to-Work promoter over the following 10 weeks
(face-to-face, email or telephone as appropriate to the
workplace size, resources and work routines). During
this time the Walk-to-Work promoters will also be
prompted and encouraged in their role by four email/
telephone contacts from the research team.
Assessment of harms
This is a low risk intervention and there were no re-
ported adverse events during the feasibility study. How-
ever, participants will be encouraged to report adverse
and serious adverse events. These may relate to road
traffic injuries and collisions; personal safety of walkers;
difficulties experienced by Walk-to-Work promoters, in-
cluding disrupting usual working relationships and em-
ployers attitudes towards time taken out of usual work
activities; and costs to employers, including disruption
to work routines, of permitting the intervention during
working hours. If adverse events are attributable to the
intervention, other relevant participants will be informed
immediately e.g. other employees taking a similar route.
It is also possible that people with low activity and no
history of walking will suffer initial muscle stiffness. In
most cases this would be mild and is a normal conse-
quence of increased physical activity. However, partici-
pants will be given information about symptoms which
may require medical attention and temporary or
permanent cessation of walking to work. Such incidents
will be recorded and monitored throughout the trial.
The control group
The control group will participate in the baseline and
one year follow-up data collection activities. No pro-
moters will be trained in the control workplaces but they
may be exposed to other workplace, local or national
walking initiatives during the intervention period. Infor-
mation about involvement in such activities will be col-
lected through the questionnaires at baseline, post-
intervention and one year follow-up.
Inclusion and exclusion criteria
Employees in participating workplaces in south-west
England and south Wales will be eligible to take part.
However, employees who already always walk or cycle to
work, who are due to retire before the one year follow-
up data collection, or who are disabled in relation to
walking, will be excluded. Employees for whom daily
driving is a key part of their role (for example, sales rep-
resentatives) will also be excluded. Workplaces with a
large proportion of staff on short-term or zero-hours
contracts are not suited because a high proportion of
these people will move on before the one-year follow-up
data collection. In addition, workplaces with firm plans
to significantly downsize or relocate during the study
period will be excluded.
Recruitment of workplaces
There will be two rounds of recruitment, during February
and March 2015 and again in February to March 2016.
Workplaces will be approached through the local Chambers
of Commerce and other employer organisations, and
will be sent basic information about the study and an in-
vitation to participate.
Allocation and randomisation
Randomisation will take place at the level of the work-
place. Employers in workplaces expressing an interest
will be asked to complete a short questionnaire to
broadly ‘match’ pairs of workplaces with respect to: size
(1–10, 50, 51–250 or 250+ employees); [31] location
(urban or suburban), and; type of business (for example,
office-based, manufacturing). Assignment of workplaces
to the intervention group, within each matched pair, will
employ concealed computer generated allocation by an
independent researcher from Bristol Randomised Trials
Collaboration to minimise selection bias. It is not pos-
sible to blind participants following randomisation for
this intervention.
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Participant recruitment
Information and leaflets and invitations to participate in
the study will be distributed to employees by the em-
ployers using their usual mode of contact, for example,
by email, attachments to wage slips, in pigeonholes or
during team meetings. This will vary by size and type of
workplace and will be noted as part of the process
evaluation.
Primary and secondary outcomes
The primary outcome, measured at baseline and one
year follow-up, is daily minutes of moderate to vigorous
physical activity (MVPA), with secondary outcomes of
overall levels of physical activity (counts per minute
(cpm)), and modal shift (number of days, over the previ-
ous five working days, when walking was the major
mode of travel to/from work). The process evaluation
will focus on: facilitators and barriers to workplace/em-
ployer participation in walk to work interventions; facili-
tators and barriers to employees walking during the
daily commute, and; physical activity/MVPA due to
walking during the journey to/from work. The economic
evaluation will examine: costs to employers and em-
ployees of implementing the Walk-to-Work scheme;
consequences for the employer (absenteeism/presentee-
ism); consequences for employees (commuting costs and
wellbeing), and consequences for the public sector
(health service use).
Assessment and follow-up
Before randomisation, participating employees will be
asked to complete a baseline questionnaire giving basic
personal data (sex, age, ethnicity), job title, mode of
transport to work, before and after work ‘routines’ af-
fecting travel mode (for example, taking young children
to school), typical commuting costs, household car own-
ership, commute related adverse events, health service
use, wellbeing (ICECAP-A [32],) and views about walk-
ing. They will also be asked to wear an accelerometer for
seven days from waking in the morning until going to
bed at night to provide an objective measurement of
physical activity (including intensity), and to carry a per-
sonal global positioning system (GPS) receiver from
leaving home until returning from work. Participants
will also be asked to complete a travel diary, recording
mode of travel, costs and journey times at baseline and
one year follow-up.
Immediately after the 10-week intervention, question-
naires will be administered in intervention and control
arms to explore: attitudes towards, and experiences of,
walking during the daily commute including perceived
barriers and facilitators, and emotional and physical
well-being. Additional questions about the acceptability
of the intervention will be included for the intervention
arm only. At one year follow-up questionnaires, acceler-
ometers and GPS receivers, and travel diaries will be ad-
ministered in intervention and control arms (as per
baseline protocol).
The costs of the intervention to employers will be
assessed by recording all time spent on training the pro-
moters, implementing the intervention among em-
ployees, and materials or resources used. Absenteeism
will be monitored using both the self-reported workplace
productivity and impairment (WPAI) questionnaire [33]
and anonymized data from workplace human resource
systems where available. Costs to participants will be
assessed by recording journey time, household commut-
ing costs and expenses at baseline and one year follow-
up using travel diaries. Self-reported measures of health
service use will allow us to provide preliminary evidence
on the savings or costs to the wider society. Employee
wellbeing will be measured using ICECAP-A [32], a re-
cently developed broader measure of benefit for use in
economic evaluations of population health and other
interventions.
Measuring physical activity
The accelerometer will generate measures of physical ac-
tivity. GPS data will be time-matched with accelerometer
data and visualised in a geographic information system
(GIS). Journeys to and from work will be identified and
the data segmented to provide a measure of duration of
the journey to work and associated physical activity. Val-
idated accelerometer thresholds will be used to compute
daily time spent in MVPA and sedentary.
Process evaluation
The process evaluation will examine the context, delivery
and response to the intervention from the perspectives of
employers, Walk-to-Work promoters and employees. In-
terviews will be conducted immediately post intervention
with a purposive sample of employees who have increased
walking during the commute (n = 18), and employees who
have not (n = 18). The sample will be stratified by work-
place characteristics and gender. A purposive sample of
employers (n = 12) and Walk-to-Work promoters (n = 12)
will also be interviewed. Data relating to recruitment and
retention rates, and responses to questions about the
intervention and travel mode in the behavioural question-
naires, will also contribute to the process evaluation.
Sample size and power calculations
Using findings from the feasibility study, the sample size
for the full-scale trial was based on an average cluster
size of 8, an ICC of 0.15, and participant attrition of
25%. With a total sample size of 678 we have 80% power
with a 5% significance level to detect a 15% increase in
mean MVPA.
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Statistical analyses
A full plan of the primary, secondary and economic ana-
lyses will be written prior to the study statistician being
unblinded. Analysis of the primary outcome (MVPA)
will be based on the data from the one year follow-up,
with each individual kept in the study arm to which their
workplace was allocated, irrespective of whether they en-
gaged with the intervention. This will be supplemented
with a sensitivity analysis, where missing outcome data
are imputed. These analyses will be as close as possible
to a full intention to treat analysis.
The treatment effect will be estimated with its 95%
confidence interval using regression methods, which will
allow any between-workplace variation in outcome to be
incorporated as a random effect (an equivalent approach
to multi-level modelling), and will allow the minimisa-
tion variables to be included as covariates. In addition
baseline MVPA and imbalanced baseline measures will
also be included as covariates, according to a process
pre-specified in the study statistical analysis plan. Linear
regression will be employed in the analysis of MVPA,
and ordered logistic regression in the analysis of the
number of days, over the previous five working days,
when walking was the major mode of travel to and from
work. If there is concern that a skewed MVPA distribu-
tion is causing problems for the linear regression, this
will be investigated in a sensitivity analysis of log-
transformed MVPA.
This approach will be adapted and repeated for sec-
ondary outcome measures, and the post-treatment mea-
sures. Evidence of differences in the treatment effect
between groups of participants defined by, in turn, age,
sex, and socio-economic status will be quantified by
interaction tests. Additional sub-group analyses will be
pre-specified in the statistical analysis plan, but only cau-
tious conclusions will be drawn from these as they are
likely to have low statistical power. Analyses of temporal
patterns of activity and of the characteristics of partici-
pant’s journeys to work will be clearly presented as ex-
ploratory in nature.
Economic evaluation
The economic evaluation will take a broad perspective
including employer, employee and public sector costs
and outcomes over the one year follow-up period. We
will estimate the cost of the Walk-to-Work promoter
training and intervention by multiplying the time spent
by trainers and employees (at training events and during
workplace contacts between promoters and participating
employees) by the wage rates. All expenses (e.g. mate-
rials, pedometers, room use, refreshments) involved in
the intervention will be documented and costed. Absen-
teeism and presenteeism will be valued using wage rates
and included as a cost to the employer. We will value
self-reported health service use in the past month at one
year follow-up using national unit costs [34]. This will
provide preliminary information on any difference in
health service costs. We will not assess cumulative
health service costs throughout the year due to the like-
lihood of recall bias. We will present results as a cost-
consequence study tabulating the costs and benefits of
the intervention borne by employers, employees and
others.
Qualitative data analysis
All recorded interviews will be fully transcribed and
anonymised. Thematic analysis [35] assisted by the
Framework [36,37] method of data management, will be
both inductive (focusing on key research questions) and
deductive (allowing themes to emerge from the views
and experiences expressed by interviewees). At least two
qualitative researchers will scrutinise the qualitative data
and subsequent interpretation.
Ethical issues and research governance
The University of Bristol is the study sponsor. National
Health Service (NHS) ethics approval was not required
as this is not a clinical trial and does not involve patients
or users of the NHS. The University of Bristol Faculty of
Medicine and Dentistry Research Ethics Committee has
given approval for the study (Application number:
131422 (6402)). The study will comply with the Eco-
nomic and Social research Council (ESRC) framework
for research ethics [38].
Full information on the research will be supplied to
participating workplaces and employees. Information
sheets and consent forms, written in plain English, will
be included with behavioural questionnaires for all eli-
gible employees at baseline. These will clearly state that
participation in the study is voluntary. All data collected
will be anonymised in any presentation of findings, and
will be stored securely in line with the University’s data
protection guidelines. A small amount of recompense
will be supplied to employees who return accelerometers
and GPS monitors in recognition of their contribution
to the research. This will be handled discretely by pro-
viding individual participating employees who meet the
compliance criteria with a plain envelope, with their
name, containing the gift voucher and thanking them for
their help with the study.
The study will be overseen by a steering group includ-
ing six independent experts in the field including a stat-
istician and a health economist. (An additional data
monitoring committee was not required because this is a
low risk public health intervention.) A Public Involve-
ment Group, comprising participants from the feasibility
study, was recruited at the end of the feasibility study
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and will be invited to meet twice a year to contribute a
lay perspective to the full-scale trial.
Discussion
The Travel to Work study is specifically concerned with
walking. Compared with other forms of physical activity,
walking is a popular, familiar, convenient, readily repeat-
able, self-reinforcing and habit-forming activity and the
main option for increasing physical activity in sedentary
populations [9]. There is a non-linear dose–response
curve to physical activity: the greatest health benefits are
achieved when the least active undertake some physical
activity. In industrialised countries, higher levels of mor-
tality and morbidity from obesity and physical inactivity-
related diseases disproportionately affect those within
poorer communities. Walking is the most obvious, low-
cost, immediate, and normative means by which to
increase physical activity and may, therefore, help to ad-
dress health inequalities.
A number of high profile active travel initiatives focus
on cycling [39,40]. However, walking may be perceived
by employees as a more practical, cheaper and safer op-
tion: it requires no special equipment and is less likely
to involve direct competition with motorised traffic for
road space, and may be easily used in combination with
public transport. Suggested benefits to employers of pro-
moting walking schemes include: increased productivity,
a reduction in sick leave, improved public image as a re-
sult of lowering the workplace’s carbon footprint and so
contributing to any Corporate Social Responsibility com-
mitments, and savings in providing car parking facilities
[24,41-44].
The study focuses on a major public health concern:
the need to increase overall rates of physical activity. In
addition, the emphasis is on rigorous evaluation using
objective measures to contribute to evidence based pol-
icy and practice. To our knowledge, this is the first full-
scale randomised controlled trial to objectively measure
(using accelerometers and GPS receivers) the effective-
ness of a workplace intervention to promote walking
during the commute to and from work.
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